Wu‐Yi Sun
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
- Hepatology top 5%
- Liver physiology and pathology
Papers in
- Hepatology 14
- Liver physiology and pathology 11
-
- Drug-Induced Hepatotoxicity and Protection 4
Wu‐Yi Sun
44 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Pharmacology 194
- Hepatology 163
- Complementary and alternative medicine 143
- Endocrine and Autonomic Systems 53
- Molecular Biology 524
Countries citing papers authored by Wu‐Yi Sun
This map shows the geographic impact of Wu‐Yi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu‐Yi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu‐Yi Sun more than expected).
Fields of papers citing papers by Wu‐Yi Sun
This network shows the impact of papers produced by Wu‐Yi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu‐Yi Sun. The network helps show where Wu‐Yi Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Wu‐Yi Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 31 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 10 | |
| 12 | 2020 | 31 | |
| 13 | 2020 | 19 | |
| 14 | 2019 | 26 | |
| 15 | 2017 | 18 | |
| 16 | 2016 | 16 | |
| 17 | 2014 | 46 | |
| 18 | 2012 | 29 | |
| 19 | 2009 | 63 | |
| 20 | 2005 | 93 |
About Wu‐Yi Sun
Wu‐Yi Sun is a scholar working on Hepatology, Pharmacology, Biological Psychiatry, Immunology and Molecular Biology, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (13 papers), Liver physiology and pathology (11 papers), Liver Disease Diagnosis and Treatment (10 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), T-cell and B-cell Immunology (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Pharmacology (194 citations), Hepatology (163 citations), Complementary and alternative medicine (143 citations), Endocrine and Autonomic Systems (53 citations) and Molecular Biology (524 citations). Wu‐Yi Sun has collaborated with scholars based in China, Saint Kitts and Nevis and Sweden. Frequent co-authors include Wei Wei, Li Wu, Hua Wang, Jingjing Wu, Qingtong Wang, Shuangying Gui, Xinran Li, Sen Zhang, Qiong Huang and Hao Liu. Their work appears in journals such as Acta Pharmacologica Sinica, Journal of Ethnopharmacology, OncoTargets and Therapy, Oncology Reports and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.